Society Letters

Letter to CMS on Medicare Coverage Restrictions for Therapeutic CGMs

November 06, 2019

To: Tamara Syrek Jensen Director, Coverage and Analysis Group, Centers for Medicare and Medicaid Services

"Our organizations support the adoption of appropriate Medicare coverage of therapeutic CGM systems for patients with diabetes, as indicated in our respective clinical practice guidelines and recommendations. Each organization developed these guidelines and recommendations through analysis of published scientific and clinical evidence, as well as the input and advice of our members. This evidence has repeatedly demonstrated that CGM systems can help certain patients improve their glucose control by providing actionable data to adjust insulin to keep blood sugar in range."

arrow Read the Full Letter

Last Updated:
Take Action

Make Your Voice Heard

Take Action
Join us in lending your voice to our online advocacy to support our policy priorities, endocrinology, and science. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.

Join us in lending your voice to our online advocacy to support our policy priorities, endocrinology, and science. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.

Back to top
Short on time?

We'll come to you...

Get updates on the latest breakthroughs, clinical practice guidelines, and career development opportunities, straight to your inbox

Then take the next step: Set up your free website account and get exclusive access to even more great tools & content!